Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Zantac Cancer Lawsuit Payouts To Provide $25K Average Per Claim In Sanofi Settlement: Report Sanofi will pay $100 million to resolve about 4,000 claims over toxic chemicals in the recalled heartburn drug, but tens of thousands of additional Zantac cancer lawsuits remain unsettled, with most pending in Delaware state court. April 23, 2024 Irvin Jackson Add Your Comments Details have emerged about a recently announced Zantac cancer settlement that Sanofi reached to resolve about 4,000 claims, indicating that the total payout will be more than $100 million, with each claimant receiving an average of $25,000. Sanofi announced the settlement agreement earlier this month, but provided no details. However, the average Zantac lawsuit payouts were outlined in a Bloomberg News report issued on April 22, which indicates that the individual amounts will vary depending on how many individuals sign on to the deal. Zantac (ranitidine) was used by millions of Americans for treatment of heartburn and acid reflux, before a Zantac recall was announced in late 2019, following the discovery that the active pharmaceutical ingredient is inherently unstable, resulting in the creation of high levels of a chemical byproduct known as N-Nitrosodimethylamine (NDMA), which is a potent human carcinogen. Despite the settlement, GlaxoSmithKline, Boehringer Ingelheim Pfizer, Sanofi and various other manufacturers, distributors, and retailers, continue to face more than 70,000 Zantac lawsuits that are still pending in various state courts nationwide, with most filed in Delaware. About 20,000 of those Delaware claims name Sanofi as a defendant, involving allegations that former users have been diagnosed with bladder cancer, liver cancer, pancreatic cancer, stomach cancer and other injuries after taking Zantac. Stay Up-to-Date About Zantac Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Zantac Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More The Zantac cancer lawsuit settlement focuses on state claims made outside of Delaware state court, which have still not yet been resolved. The litigation was originally focused in the federal court system, where all Zantac lawsuits were centralized before Judge Robin L. Rosenberg in the U.S. District Court for the Southern District of Florida, for coordinated discovery and pretrial proceedings. However, in 2022 Judge Rosenberg issued a controversial ruling that excluded all of the plaintiffs’ expert witnesses from testifying at trial under federal evidentiary rules, resulting in all Zantac lawsuits pending in the federal court system being dismissed While appeals have been filed to challenge Judge Rosenberg’s ruling, the decision did not have any impact on lawsuits filed in California, Delaware and various other state courts, where different standards for the admissibility of expert witness testimony apply. Delaware Superior Court Judge Vivian Medinilla is currently weighing whether Zantac cases in that state should be dismissed on similar grounds as the federal cases, following hearings held in January. Her decision could determine whether the bulk of Zantac lawsuits filed in that state move forward. Much like the federal cases, if manufacturers can convince Judge Medinilla to exclude all of the plaintiffs’ expert witnesses, it would effectively kill the litigation in that venue, where most claims have been filed since the federal MDL was dismissed. May 2024 Zantac Lawsuits Update Sanofi’s Zantac settlement announcement comes after GlaxoSmithKline settled several individual Zantac lawsuits before they went to trial in California state court. GlaxoSmithKline announced two Zantac settlements in February, and another last November. Like Sanofi, the company has claimed it still plans to defend itself against the remaining lawsuits. However, it also made those statements after previous settlements, and the drug maker faces several additional Zantac lawsuits that are scheduled for trial in California in the coming months. While the results of those trials will have no binding impact on other claims pending nationwide, they are likely to be closely watched and the average Zantac cancer lawsuit payouts awarded by juries may send a signal about how similar evidence and testimony will be viewed in thousands of other cases. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior legal and investigative journalist with more than 30 years of experience covering complex issues at the intersection of law, politics, and environmental policy. He began his reporting career in 1991 after graduating from Wayne. Tags: Boehringer Ingelheim, California, Cancer, Delaware, GlaxoSmithKline, Heartburn, Heartburn Drug, NDMA, Pfizer, Sanofi, Zantac, Zantac Recall More Zantac Lawsuit Stories Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall June 18, 2025 Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: today) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025) Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: today) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025) Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: 3 days ago) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)
Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: today) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)
Judge Orders Cartiva Implant Settlement Talks Before Trial in Aug. 2026 (Posted: today) The first Cartiva toe implant trial has been delayed until August 2026, with parties ordered to engage in settlement negotiations. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (06/26/2025)Failed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)
Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: 3 days ago) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)